Determinant [ftcn]
Survival Rate [qnco]
Implantation [topp]
Cardioverter-Defibrillator [medd]
Capability [qlco]
Background [cnce]
Patients [podg]
High Risk [qlco]
Sudden Cardiac Death [patf]
Increasing [ftcn]
Implantable Cardioverter-Defibrillators [medd]
Contribute [acty]
Improved [qlco]
Survival [acty]
Patients [podg]
High Risk [qlco]
Sudden Cardiac Death [patf]
Aim [idcn]
To [qlco]
Assess [acty]
Survival Rate [qnco]
Implantation [topp]
Implantable Cardioverter-Defibrillators [medd]
Capability [qlco]
Population [qnco]
Using [ftcn]
Multivariate Analysis [qnco]
Attempt [evnt]
To [qlco]
Factor [ftcn]
Associated [qlco]
Worsening [qlco]
Survival Rate [qnco]
Methods [inpr]
Population [qnco]
Patients [podg]
Implantable Cardioverter-Defibrillators [medd]
Implantation [topp]
Primary [qlco]
Secondary Prevention [topp]
Sudden Cardiac Death [patf]
Select [acty]
Patients [podg]
coronary artery disease [dsyn]
Cardiomyopathy, Dilated [dsyn]
Females [fndg]
Males [fndg]
Mean [qnco]
Age [orga]
Range [qnco]
Implantable Cardioverter-Defibrillators [medd]
Implantation [topp]
Protocols [inpr]
In [qnco]
Hospital [hcro, mnob]
Out-patient [podg]
Records [inpr]
reviewed [inpr]
Following [tmco]
Clinical [qlco]
procedures [inpr]
variables [qlco]
Age [orga]
Gender [orga]
Left ventricular ejection fraction [clna]
New York Heart Association Class [fndg]
Functional [ftcn]
Mean Heart Rate [qnco]
Width [qnco]
Anti-arrhythmic [phsu]
Implantable Cardioverter-Defibrillators [medd]
interventions [hlca]
Type [qlco]
Sudden Cardiac Death [patf]
Prevention [topp]
Implantable Cardioverter-Defibrillators [medd]
Type [qlco]
Perform [ftcn]
Defibrillation Threshold [qnco]
Testing [ftcn]
establish [qlco]
Defibrillation [topp]
Safety [hcpp]
Margin [spco]
Implantable Cardioverter-Defibrillators [medd]
Implantation [topp]
Ventricular Lead [medd]
Location [spco]
History [ocdi]
Cardiovascular disease [dsyn]
Arrhythmia [patf]
Medications [phsu]
Amiodarone [orch, phsu]
Sotalol [orch, phsu]
Beta-Blockers [phsu]
Angiotensin-Converting Enzyme Inhibitors [phsu]
receptor [aapp, rcpt]
Statins [orch, phsu]
Loop Diuretics [phsu]
Aldosterone Antagonists [phsu]
Date [tmco]
Death [orgf]
Established [qlco]
contacting [ftcn]
Family [famg]
Hospital [hcro, mnob]
admitted [hlca]
Death [orgf]
General practitioner [prog]
Caring [inbe]
verification [resa]
Death Certificates [inpr, mnob]
Result [ftcn]
Mean [qnco]
Follow-up [fndg]
days [tmco]
Patients [podg]
Died [orgf]
Known [qlco]
Death [orgf]
included [ftcn]
Sudden death [patf]
Patients [podg]
Heart failure [dsyn]
Patients [podg]
Patients [podg]
Respiratory Failure [dsyn]
Bleeding [patf]
Diathesis [clna]
Lung Cancer [neop]
Colorectal Cancer [neop]
traffic accident [inpo]
Stroke [dsyn]
Patients [podg]
Comparison [acty]
Primary [qlco]
Secondary Prevention [topp]
Patients [podg]
Performed [ftcn]
Mean [qnco]
Width [qnco]
MS [aapp, enzy]
RESTING HEART RATE [fndg]
Left ventricular ejection fraction [clna]
Significance values [qlco]
Cutoff [ftcn]
Improved [qlco]
Survival [acty]
Using [ftcn]
ROC Curves [qnco]
heart rate [clna]
Observed [ftcn]
Sudden Cardiac Death [patf]
Patients [podg]
Kaplan-Meier Analysis [qnco]
Including [ftcn]
Parameters [fndg]
Survival [acty]
Parameters [fndg]
Identified [qlco]
Type [qlco]
Prevention [topp]
Presence [topp]
Cardiomyopathy [dsyn]
Tachycardia, Ventricular [patf]
heart rate [clna]
Width [qnco]
Left ventricular ejection fraction [clna]
New York Heart Association Class [fndg]
Perform [ftcn]
Defibrillation Threshold [qnco]
Testing [ftcn]
Statin [orch, phsu]
diuretic treatment [topp]
Multivariate Analysis [qnco]
Risk [qlco]
Death [orgf]
Increased [qnco]
Mean [qnco]
Fold [spco]
Increase [ftcn]
Risk [qlco]
Defibrillation Threshold [qnco]
Testing [ftcn]
Fold [spco]
Increase [ftcn]
Risk [qlco]
New York Heart Association Class III [fndg]
Fold [spco]
Increase [ftcn]
Risk [qlco]
Statin [orch, phsu]
Fold [spco]
Increase [ftcn]
Risk [qlco]
Mean Heart Rate [qnco]
Width [qnco]
MS [aapp, enzy]
Increased [qnco]
Survival [acty]
Conclusions [idcn]
Death rate [qnco]
High [qlco]
Patients [podg]
Left ventricular ejection fraction [clna]
New York Heart Association Class III [fndg]
Defibrillation Threshold [qnco]
Testing [ftcn]
Performed [ftcn]
Statin [orch, phsu]
treatment [ftcn]
Patients [podg]
Indications [idcn]
Cardiac Resynchronization Therapy [topp]
considered [idcn]
heart rate [clna]
Width [qnco]
MS [aapp, enzy]
Independent [idcn]
protective factors [biof]
heart rate [clna]
Observed [ftcn]
Sudden Cardiac Death [patf]
Patients [podg]
Sickness [fndg]
Implantable Cardioverter-Defibrillators [medd]
Patients [podg]
Live [qlco]
short [qlco]
Time [tmco]
Presence [topp]
Atrial Fibrillation [patf]
Anti-arrhythmic [phsu]
Implantable Cardioverter-Defibrillators [medd]
interventions [hlca]
Implantable Cardioverter-Defibrillators [medd]
Type [qlco]
Revascularisation [topp]
Approach [spco]
Not [ftcn]
Affect [menp]
Survival [acty]
Mortality [qnco]
